Skip to main content

Advertisement

Table 1 General characteristics of study participants for treatment with ASAQ and AL by study site in Togo, 2012–2013

From: Therapeutic efficacy trial of artemisinin-based combination therapy for the treatment of uncomplicated malaria and investigation of mutations in k13 propeller domain in Togo, 2012–2013

Drug Site N Male/female Mean age, months (SD) Mean temperature, °C (SD) Geometric mean parasitaemia, µL−1 (95 % CI)
ASAQ Lomé 93 44/49 37.6 (16.2) 39.1 (0.9) 23,906 (2187–198,250)
ASAQ Sokodé 86 39/47 35.6 (15.1) 38.8 (0.9) 38,720 (2026–240,000)
ASAQ Niamtougou 83 48/35 37.8 (15.4) 38.6 (1.0) 34,242 (2226–235,000)
AL Lomé 90 49/41 36.6 (16.8) 39.1 (0.9) 29,986 (2076–215,786)
AL Sokodé 88 51/37 35.5 (16.5) 38.8 (0.9) 31,824 (2060–230,211)
AL Niamtougou 83 43/40 36.9 (15.3) 38.5 (1.0) 29,685 (2172–224,250)